Can Apple Inc. (AAPL)’s Large Screen iPhone 6 End Samsung’s Dominance?

Apple Inc. (NASDAQ:AAPL)’s iPhone 6 is rumored to come with a choice of two screen sizes, one a 4.7-inch model and the other 5.5-inch model. Samsung, which is a market leader in large screen smartphones seems to have taken a note of it, at least the company’s new commercial points to that.

Scott Martin, the CEO of Accent Asset Management, Independent Women’s Forum’s Hadley Heath Manning and national Republican fundraiser Noelle Nikpour, were seen discussing the continuing rivalry on the smartphone market between Apple Inc. (NASDAQ:AAPL) and Samsung on Fox Business News.

“It’s not too late; I mean Samsung has made some really big strides you know. This is coming down to a Coke, Pepsi thing now. There are two horses left in the smartphone race, you know Nokia is out of the picture, HTC, Blackberry totally irrelevant. So you are going to see these guys fight out pretty closely […] I’ll tell you what’s going to be even funnier, this is going to play out in the market but also in the court. These guys sue each other every month for billions of dollars for all kinds of funny stuff,” Mr. Martin said.

Manning feels that people are going to buy Apple Inc. (NASDAQ:AAPL)’S phones. According to her the company is the market leader with a 41% market share while Samsung’s market share is still under 30%, so even if there is going to be a war between the two companies, there are a lot of people who love Apple Inc. (NASDAQ:AAPL).

“When you have such competition like that, the winner is the consumer. I mean because they are going to perfect it, they are going to make it right and let them battle it out. Let them have size, it will be going on constantly back and forth because the winner is going to be you, it’s going to be I, it’s going to be the consumer,” Nikpour added.

Disclosure: None

Biotech Insider Alert - $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!